Purchase Order HHSN261201700367P

<p>The National Cancer Institute awarded a purchase order to Sigma-Aldrich, Inc. for $7,500.00 on May 3, 2018, with a completion date of May 26, 2018. No set-aside was used. Performance takes place in St. Louis, Missouri. The order is firm fixed price for specialized laboratory chemicals, biological materials, or research supplies typical of the vendor's federal contracting footprint serving civilian research agencies.</p>

<p>The National Cancer Institute awarded a purchase order to Omega Scientific, Inc. for $13,201.07 on February 28, 2018. The order, which carried no set-aside designation, procured laboratory supplies with a firm fixed price. Work is performed at Tarzana, California. The order was originally due for completion on February 27, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $17,948.50 on September 19, 2019, for drugs and biologicals, with ultimate completion on October 19, 2019. Place of performance is Bethesda, Maryland. The order uses firm fixed-price pricing with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to Omega Scientific, Inc. for $24,236.19 on August 5, 2019. The order procures drugs and biologicals, with completion by September 5, 2019. Performance is located in Tarzana, California. No small business set-aside applies; pricing is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Sigma-Aldrich, Inc. for fetal bovine serum with a ceiling value of $14,750.00 on August 22, 2019, with ultimate completion by September 22, 2019. Place of performance is Bethesda, Maryland. The order carries firm fixed-price pricing and no small-business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Government Scientific Source Inc., a small business, valued at $14,877.85 on July 18, 2017. Performance is located in Bethesda, Maryland. The order was issued under firm fixed pricing with no set-aside category. Ultimate completion is scheduled for December 31, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Sigma-Aldrich, Inc. for one Vacuubrand Chemistry Vacuum System (model MD 4C NT, 110V) with a ceiling value of $5,000.00 on July 12, 2017. Performance takes place in Bethesda, Maryland, with an ultimate completion date of July 20, 2017. The order carries firm fixed pricing and no small-business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Karebay Biochem Inc. for $22,000 on September 11, 2017, with an ultimate completion date of October 11, 2017. Place of performance is Bethesda, Maryland. The order is for custom organic chemical synthesis and specialized peptide synthesis services in support of cancer research.</p>

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on September 5, 2018, with an ultimate completion date of October 5, 2018. Performance occurs in Bethesda, Maryland. The order is a firm fixed price purchase of molecular biology products, reagents, and research supplies. No set-aside was used.</p>